Perioperative Immunotherapy for Resectable Limited-Stage SCLC
Perioperative Immunotherapy for Resectable Limited-Stage SCLC
Recruiting · NCT07109401 · Registry updated 2025-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Immunotherapy for Resectable Limited-Stage SCLC | Limited Stage Lung Small Cell Carcinoma; Perioperative Immunotherapy; Resectable Small Cell Lung Cancer | Recruiting | Phase 2 | 2025-08-07 | NCT07109401 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |